For the most up to date information on COVID-19 please visit the Department of Health Website.
Learn more about how the AIHW is assisting the COVID-19 response and our broader work on communicable diseases.
In Australia, publicly funded alcohol and other drug treatment services are available in all states and territories—most are funded by state and territory governments, and some are funded by the Australian Government.
Clients seeking treatment for their own drug use nominate a principal drug of concern, and additional drugs where applicable, which may be related to licit drug use (the use of legal drugs in a legal manner, including tobacco smoking and alcohol consumption) or illicit drug use. Illicit drug use refers to the:
Depending on a client's circumstances, services can be delivered in residential or non-residential settings and include treatment such as detoxification and rehabilitation, counselling, and pharmacotherapy.
Opioid pharmacotherapy is one of the main treatment options for dependence on opioid drugs, such as heroin and morphine. Treatment involves replacing the opioid drug of dependence with a legally obtained, longer-lasting opioid that is taken orally. In Australia, clients attend dosing point sites (for example, pharmacies) regularly to take the dose of their prescribed medication under the supervision of a pharmacist or other health professional.
DoH (Department of Health) 2017. The National Drug Strategy 2017–2026. Canberra: Commonwealth of Australia.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.